NCT00252382 2018-09-24Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLCSunesis PharmaceuticalsPhase 2 Completed31 enrolled 6 charts
NCT00298896 2018-07-26Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung CancerSunesis PharmaceuticalsPhase 2 Completed55 enrolled 10 charts
NCT00408603 2017-07-27Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian CancerSunesis PharmaceuticalsPhase 2 Completed183 enrolled 15 charts